Resmed RMD
NYSE RMD
$231.52 +3.08 (+1.35%)
At close: Aug 21, 2026 · 4:00 PM EDT

Resmed (RMD) Equity Income (2020 - 2022)

Resmed's (RMD) quarterly Equity Income came in at -$1.7 million in Q1 2022, down 137.18% YoY from $4.7 million in Q1 2021, and up 60.6% on a QoQ basis from -$4.4 million in Q4 2021.

Resmed (RMD) Equity Income (2020 - 2022) Analysis & Trends

Resmed (RMD) has 3 years of Equity Income data on file, last reported at -$1.7 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 2.23 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 6.10 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -
10 Align Technology 11.61 Bn 10.51 Bn 757.43 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2022 -1.74 Mn
Dec 31, 2021 -4.40 Mn
Sep 30, 2021 5.61 Mn
Mar 31, 2021 4.67 Mn
Dec 31, 2020 -3.70 Mn
Sep 30, 2020 8.50 Mn